Search results

Found 7,457 pages
AUTHOR: Selina McKee

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Teva buys Allergan’s drug distribution group

Teva Pharmaceutical Industries has unveiled plans to buy Allergan-owned US generics giant Anda for $500 million. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/teva_buys_allergans_drug_distribution_group_1090400

MundiPharma, Orexo file Zubsolv in Europe

UK-based MundiPharma and Swedish group Orexo's have filed opioid dependence drug Zubsolv in Europe. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/mundipharma,_orexo_file_zubsolv_in_europe_1152749

GP closures at record levels

The number of GP practices shutting their doors in England has risen to record highs, forcing more than a quarter of a million people to change their family doctor. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/gp_closures_at_record_levels_1191002

Bladder cancer nod for BMS’ Opdivo

The US Food and Drug Administration has approved Bristol-Myers Squibb's immunotherapy Opdivo as a treatment for the most common form of bladder cancer. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/bladder_cancer_nod_for_bms_opdivo_1185762

Merck joins the pack circling Medivation

Merck & Co is reportedly the latest pharma to consider snapping up US cancer biotech Medivation. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/merck_joins_the_pack_circling_medivation_1102657

Teva drops development of laquinimod

Teva Pharmaceutical Industries has decided not to pursue development of laquinimod, and has returned rights to the drug back to Swedish group Active Biotech. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/teva_drops_development_of_laquinimod_1251494

Merck considers future of consumer health unit

Germany’s Merck is considering the future of its consumer health segment, including a potential full or partial sale of the business as well as new strategic partnerships. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/merck_considers_future_of_consumer_health_unit_1204315

Martindale’s oral epilepsy drug bags EU nods

UK-based Martindale Pharma has announced regulatory clearance of an oral formulation of its epilepsy therapy clobazam in Europe. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/martindales_oral_epilepsy_drug_bags_eu_nods_1174519

Pfizer’s Epogen/Procrit biosimilar wins US backing

Pfizer’s biosimilar of Amgen’s epoetin alfa (Epogen/Procrit) has won backing in the US for approval across all proposed indications. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/pfizers_epogenprocrit_biosimilar_wins_us_backing_1194418

Setback for AZ’ Imfinzi lung cancer combination

AstraZeneca’s Imfinzi has failed to show a significant benefit over standard of care (SoC) chemotherapy on overall survival in certain patients with lung cancer. - News - PharmaTimes

by Selina McKee

www.pharmatimes.com/news/setback_for_az_imfinzi_lung_cancer_combination_1261005

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download